Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-20747-x, published online 29 September 2022
The Supplementary Information 2 file published with this Article contained an error in Supplementary Figue 2 (D) where the antibody titers for BNT162b2 and mRNA-1273 were reversed. The original Supplementary Information 2 file is provided below.
This error has now been corrected in the Supplementary Information 2 file that accompanies the original Article.
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sugiyama, A., Kurisu, A., Nagashima, S. et al. Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers. Sci Rep 13, 1906 (2023). https://doi.org/10.1038/s41598-023-28884-7
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-023-28884-7
